214 related articles for article (PubMed ID: 18222354)
1. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.
Shiffman D; Chasman DI; Zee RY; Iakoubova OA; Louie JZ; Devlin JJ; Ridker PM
J Am Coll Cardiol; 2008 Jan; 51(4):444-8. PubMed ID: 18222354
[TBL] [Abstract][Full Text] [Related]
2. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
Iakoubova OA; Tong CH; Rowland CM; Kirchgessner TG; Young BA; Arellano AR; Shiffman D; Sabatine MS; Campos H; Packard CJ; Pfeffer MA; White TJ; Braunwald E; Shepherd J; Devlin JJ; Sacks FM
J Am Coll Cardiol; 2008 Jan; 51(4):435-43. PubMed ID: 18222353
[TBL] [Abstract][Full Text] [Related]
3. Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
Williams P; Pendyala L; Superko R
BMC Med Genet; 2011 Mar; 12():42. PubMed ID: 21435211
[TBL] [Abstract][Full Text] [Related]
4. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
Shiffman D; Sabatine MS; Louie JZ; Kirchgessner TG; Iakoubova OA; Campos H; Devlin JJ; Sacks FM
Am J Cardiol; 2010 May; 105(9):1300-5. PubMed ID: 20403483
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
Iakoubova OA; Sabatine MS; Rowland CM; Tong CH; Catanese JJ; Ranade K; Simonsen KL; Kirchgessner TG; Cannon CP; Devlin JJ; Braunwald E
J Am Coll Cardiol; 2008 Jan; 51(4):449-55. PubMed ID: 18222355
[TBL] [Abstract][Full Text] [Related]
6. KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study.
Iakoubova OA; Robertson M; Tong CH; Rowland CM; Catanese JJ; Blauw GJ; Jukema JW; Murphy MB; Devlin JJ; Ford I; Shepherd J
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):455-61. PubMed ID: 20215968
[TBL] [Abstract][Full Text] [Related]
7. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.
Arsenault BJ; Boekholdt SM; Hovingh GK; Hyde CL; DeMicco DA; Chatterjee A; Barter P; Deedwania P; Waters DD; LaRosa JC; Pedersen TR; Kastelein JJ;
Circ Cardiovasc Genet; 2012 Feb; 5(1):51-7. PubMed ID: 22135385
[TBL] [Abstract][Full Text] [Related]
8. KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy.
Li Y; Iakoubova OA; Shiffman D; Devlin JJ; Forrester JS; Superko HR
Am J Cardiol; 2010 Oct; 106(7):994-8. PubMed ID: 20854963
[TBL] [Abstract][Full Text] [Related]
9. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.
Ridker PM; MacFadyen JG; Glynn RJ; Chasman DI
Circ Cardiovasc Genet; 2011 Jun; 4(3):312-7. PubMed ID: 21493817
[TBL] [Abstract][Full Text] [Related]
10. Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect.
Peng P; Lian J; Huang RS; Xu L; Huang Y; Ba Y; Yang X; Huang X; Dong C; Zhang L; Ye M; Zhou J; Duan S
PLoS One; 2012; 7(12):e50126. PubMed ID: 23236363
[TBL] [Abstract][Full Text] [Related]
11. The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.
Shiffman D; O'Meara ES; Rowland CM; Louie JZ; Cushman M; Tracy RP; Devlin JJ; Psaty BM
BMC Cardiovasc Disord; 2011 Mar; 11():10. PubMed ID: 21406102
[TBL] [Abstract][Full Text] [Related]
12. Investigation of KIF6 Trp719Arg in a case-control study of myocardial infarction: a Costa Rican population.
Bare LA; Ruiz-Narvaéz EA; Tong CH; Arellano AR; Rowland CM; Catanese JJ; Sacks FM; Devlin JJ; Campos H
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927332
[TBL] [Abstract][Full Text] [Related]
13. The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis.
Ruiz-Ramos D; Hernández-Díaz Y; Tovilla-Zárate CA; Juárez-Rojop I; López-Narváez ML; González-Castro TB; Torres-Hernández ME; Baños-González MA
Hereditas; 2015; 152():3. PubMed ID: 28096762
[TBL] [Abstract][Full Text] [Related]
14. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
Hopewell JC; Parish S; Clarke R; Armitage J; Bowman L; Hager J; Lathrop M; Collins R;
J Am Coll Cardiol; 2011 May; 57(20):2000-7. PubMed ID: 21458191
[TBL] [Abstract][Full Text] [Related]
15. Investigation of KIF6 Trp719Arg in a case-control study of coronary artery disease in Western Indians.
Bhanushali AA; Contractor A; Shah VT; Das BR
Genet Test Mol Biomarkers; 2011 Dec; 15(12):883-6. PubMed ID: 21810021
[TBL] [Abstract][Full Text] [Related]
16. Association of KIF6 variant with lipid level and angiographic coronary artery disease events risk in the Han Chinese population.
Wu G; Li GB; Dai B
Molecules; 2012 Sep; 17(9):11269-80. PubMed ID: 23001387
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the KIF6 region and coronary event reduction from statin therapy.
Li Y; Sabatine MS; Tong CH; Ford I; Kirchgessner TG; Packard CJ; Robertson M; Rowland CM; Bare LA; Shepherd J; Devlin JJ; Iakoubova OA
Hum Genet; 2011 Jan; 129(1):17-23. PubMed ID: 20886236
[TBL] [Abstract][Full Text] [Related]
18. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
Atherosclerosis; 2012 Feb; 220(2):456-62. PubMed ID: 22192511
[TBL] [Abstract][Full Text] [Related]
19. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.
Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM
JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855
[TBL] [Abstract][Full Text] [Related]
20. Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.
Li Y; Chen Z; Song H
Lipids Health Dis; 2018 Jan; 17(1):4. PubMed ID: 29304815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
